Advertisement

Parasitic and Fungal Triggers

  • Gary Sterba
  • Yonit Sterba
Chapter

Abstract

Infections caused by parasites and fungi can trigger the cytokine storm syndrome (CSS). These infections causing CSS can occur together with acquired immunodeficiencies, lymphomas, the use of immunosuppressive medications, transplant recipients, cancer, autoinflammatory and autoimmune diseases or less frequently in healthy individuals. Histoplasma, Leishmania, Plasmodium, and Toxoplasma are the most frequent organisms associated with a CSS. It is very important to determine a previous travel history when evaluating a patient with a CSS triggered by these organisms as this may be the clue to the causal agent. Even though CSS is treated with specific therapies, an effort to find the causal organism should be carried out since treatment of the infectious organism may stop the CSS. Diagnosing a CSS in the presence of parasitic or fungal sepsis should also lead to the study of an altered cytotoxic or hemophagocytic response in the susceptible host.

References

  1. 1.
    Reiner, A. P., & Spivak, J. L. (1988). Hematophagic histiocytosis. A report of 23 new patients and a review of the literature. Medicine (Baltimore), 67, 369–388.CrossRefGoogle Scholar
  2. 2.
    Fries, W., Cottone, M., & Cascio, A. (2013). Systematic review: Macrophage activation syndrome in inflammatory bowel disease. Alimentary Pharmacology & Therapeutics, 37(11), 1033–1045.CrossRefGoogle Scholar
  3. 3.
    Singh, Z. N., Rakheja, A., Yadav, T. P., & Shome, J. (2005). Infection-associated haemophagocytosis: The tropical spectrum. Clinical and Laboratory Haematology, 27(5), 312–315.PubMedCrossRefGoogle Scholar
  4. 4.
    Rajagopala, S., & Singh, N. (2012). Diagnosing and treating haemophagocytic Lymphohistiocytosis in the tropics: Systematic review from the Indian subcontinent. Acta Medica Academica, 41, 161–174.PubMedCrossRefGoogle Scholar
  5. 5.
    Brito-Zerón, P., Bosch, X., Pérez-de-Lis, M., Pérez-Álvarez, R., Fraile, G., Gheitasi, H., et al. (2016). Infection is the major trigger of hemophagocytic syndrome in adult patients treated with biological therapies. Seminars in Arthritis and Rheumatism, 45(4), 391–399.PubMedCrossRefGoogle Scholar
  6. 6.
    Shailender, B., Bauer, F., & Bilgrami, S. A. (2003). Candidiasis-associated Hemophagocytic Lymphohistiocytosis in a patient infected with human immunodeficiency virus. Clinical Infectious Diseases, 37(11), 161–166.CrossRefGoogle Scholar
  7. 7.
    Grau, G. E., Taylor, T. T., Molyneux, M. E., Wirima, J. J., Vassalli, P., Hommel, M., et al. (1989). Tumor necrosis factor and disease severity in children with falciparum malaria. The New England Journal of Medicine, 320, 1586.PubMedCrossRefGoogle Scholar
  8. 8.
    Ioannidis, L. J., Nie, C. Q., & Hansen, D. S. (2014). The role of chemokines in severe malaria: More than meets the eye. Parasitology, 141(5), 602–613.PubMedCrossRefGoogle Scholar
  9. 9.
    Veerakul, G., Sanpakit, K., Tanphaichitr, V. S., Mahasandana, C., & Jirarattanasopa, N. (2002). Secondary hemophagocytic lymphohistiocytosis in children: An analysis of etiology and outcome. Journal of the Medical Association of Thailand, 85(Suppl 2), S530–S541.Google Scholar
  10. 10.
    Saribeyoglu, E. T., Anak, S., Agaoglu, L., Boral, O., Unuvar, A., & Devecioglu, O. (2004). Secondary hemophagocytic lymphohistiocytosis induced by malaria infection in a child with Langerhans cell histiocytosis. Pediatric Hematology and Oncology, 21(3), 267–272.PubMedCrossRefPubMedCentralGoogle Scholar
  11. 11.
    Weeratunga, P., Rathnayake, G., Sivashangar, A., Karunanayake, P., Gnanathasan, A., & Chang, T. (2016). Plasmodium falciparum and mycoplasma pneumoniae co-infection presenting with cerebral malaria manifesting orofacial dyskinesia and Haemophagocytic lymphohistiocytosis. Malaria Journal, 15, 461.PubMedPubMedCentralCrossRefGoogle Scholar
  12. 12.
    Ullah, W., Abdullah, H. M., Qadir, S., & Shahzad, M. A. (2016). Haemophagocytic lymphohistiocytosis (HLH): A rare but potentially fatal association with plasmodium vivax malaria. British Medical Journal Case Reports, 2016, bcr2016215366.Google Scholar
  13. 13.
    Bhagat, M., Kanhere, S., Kadakia, P., Phadke, V., George, R., & Chaudhari, K. (2015). Haemophagocytic lymphohistiocytosis: a cause of unresponsive malaria in a 5-year-old girl. Paediatrics and International Child Health, 35(4), 333–336.PubMedCrossRefPubMedCentralGoogle Scholar
  14. 14.
    Ohno, T., Shirasaka, A., Sugiyama, T., & Furukawa, H. (1996). Hemophagocytic syndrome induced by plasmodium falciparum malaria infection. International Journal of Hematology, 64(3–4), 263–266.PubMedCrossRefPubMedCentralGoogle Scholar
  15. 15.
    Ohnishi, K., Mitsui, K., Komiya, N., Iwasaki, N., Akashi, A., & Hamabe, Y. (2007). Clinical case report: Falciparum malaria with hemophagocytic syndrome. The American Journal of Tropical Medicine and Hygiene, 76, 1016–1018.PubMedCrossRefPubMedCentralGoogle Scholar
  16. 16.
    Bae, E., Jang, S., Park, C. J., & Chi, H. S. (2011). Plasmodium vivax malaria-associated hemophagocytic lymphohistiocytosis in a young man with pancytopenia and fever. Annals of Hematology, 90(4), 491–492. Epub 2010 Aug 19.PubMedCrossRefPubMedCentralGoogle Scholar
  17. 17.
    Sung, P. S., Kim, I. H., Lee, J. H., & Park, J. W. (2011). Hemophagocytic lymphohistiocytosis (HLH) associated with plasmodium vivax infection: Case report and review of the literature. Chonnam Medical Journal, 47(3), 173–176. Epub 2011 Dec 26.PubMedPubMedCentralCrossRefGoogle Scholar
  18. 18.
    Poisnel, E., Ebbo, M., Berda-Haddad, Y., Faucher, B., Bernit, E., Carcy, B., et al. (2013). Babesia microti: An unusual travel-related disease. BMC Infectious Diseases, 13, 99.PubMedPubMedCentralCrossRefGoogle Scholar
  19. 19.
    Visentin, S., Baudesson de Chanville, A., Loosveld, M., Chambost, H., & Barlogis, V. (2013). Infantile visceral leishmaniasis, an etiology of easily curable hemophagocytic lymphohistiocytosis syndrome. Archives de Pédiatrie, 20(11), 1225–1229. Epub 2013 Sep 26.PubMedCrossRefGoogle Scholar
  20. 20.
    Marom, D., Offer, I., Tamary, H., Jaffe, C. L., & Garty, B. (2001). Hemophagocytic Lymphohistiocytosis associated with visceral leishmaniasis. Pediatric Hematology and Oncology, 18(1), 65.PubMedCrossRefPubMedCentralGoogle Scholar
  21. 21.
    Cancado, G. G., Freitas, G. G., Faria, F. H., de Macedo, A. V., & Nobre, V. (2013). Hemophagocytic lymphohistiocytosis associated with visceral leishmaniasis in late adulthood. The American Journal of Tropical Medicine and Hygiene, 88(3), 575–577.PubMedPubMedCentralCrossRefGoogle Scholar
  22. 22.
    Bode, S. F., Bogdan, C., Beutel, K., Behnisch, W., Greiner, J., Henning, S., et al. (2014). Hemophagocytic lymphohistiocytosis in imported pediatric visceral leishmaniasis in a nonendemic area. The Journal of Pediatrics, 165(1), 147–153. Epub 2014 May 3.PubMedCrossRefGoogle Scholar
  23. 23.
    Watkins, E. R., Shamasunder, S., Cascino, T., White, K. L., Katrak, S., Bern, C., et al. (2014). Visceral leishmaniasis-associated hemophagocytic lymphohistiocytosis in a traveler returning from a pilgrimage to the Camino de Santiago. Journal of Travel Medicine, 21(6), 429–432. Epub 2014 Aug 21.PubMedCrossRefPubMedCentralGoogle Scholar
  24. 24.
    Scalzone, M., Ruggiero, A., Mastrangelo, S., Trombatore, G., Ridola, V., Maurizi, P., et al. (2016). Hemophagocytic lymphohistiocytosis and visceral leishmaniasis in children: Case report and systematic review of literature. Journal of Infection in Developing Countries, 10(1), 103–108.PubMedCrossRefPubMedCentralGoogle Scholar
  25. 25.
    Hernández-Jiménez, P., Díaz-Pedroche, C., Laureiro, J., Madrid, O., Martín, E., & Lumbreras, C. (2016). Hemophagocytic lymphohistiocytosis: Analysis of 18 cases. [article in Spanish]. Medicina Clínica (Barcelona), 147(11), 495–498. Epub 2016 Oct 7.CrossRefGoogle Scholar
  26. 26.
    Aydın Teke, T., Metin Timur, Ö., Gayretli Aydın, Z. G., Öz, N., Bayhan, G. İ., Yılmaz, N., et al. (2015). Three pediatric cases of leishmaniasis with different clinical forms and treatment regimens. Türkiye Parazitolojii Dergisi, 39(2), 147–150. in Turkish.PubMedPubMedCentralGoogle Scholar
  27. 27.
    Ranjan, P., Kumar, V., Ganguly, S., Sukumar, M., Sharma, S., Singh, N., et al. (2016). Hemophagocytic lymphohistiocytosis associated with visceral leishmaniasis: Varied presentation. Indian Journal of Hematology and Blood Transfusion, 32(Suppl 1), 351–354.  https://doi.org/10.1007/s12288-015-0541-2. Epub 2015 Apr 28.CrossRefPubMedPubMedCentralGoogle Scholar
  28. 28.
    Michel, G., Simonin, G., Perrimond, H., & Coignet, J. (1988). Syndrome of activation of the mononuclear phagocyte system. Initial manifestation of visceral leishmaniasis. Archives Françaises de Pédiatrie, 45, 45–46.PubMedPubMedCentralGoogle Scholar
  29. 29.
    Kilani, B., Ammari, L., Kanoun, F., Ben Chaabane, T., Abdellatif, S., & Chaker, E. (2006). Hemophagocytic syndrome associated with visceral leishmaniasis. International Journal of Infectious Diseases, 10, 85–86.PubMedCrossRefPubMedCentralGoogle Scholar
  30. 30.
    Levy, L., Nasereddin, A., Rav-Acha, M., Kedmi, M., Rund, D., & Gatt, M. E. (2009). Prolonged fever, Hepatosplenomegaly, and pancytopenia in a 46-year-old woman. PLoS Medicine, 6(4), e1000053.  https://doi.org/10.1371/journal.pmed.1000053CrossRefPubMedPubMedCentralGoogle Scholar
  31. 31.
    Thabet, F., Tabarki, B., Fehem, R., Yacoub, M., Selmi, H., & Essoussi, A. S. (1999). Syndrome of inappropriate macrophage activation associated with infantile visceral leishmaniasis. La Tunisie Médicale, 77, 648–650.PubMedGoogle Scholar
  32. 32.
    Nadrid, A., Pousse, H., Laradi-Chebil, S., Khelif, A., Bejaoui, M., Besbes, A., et al. (1996). Infantile visceral leishmaniasis: Difficult diagnosis in cases complicated by hemophagocytosis. Archives de Pédiatrie, 3, 881–883.PubMedCrossRefGoogle Scholar
  33. 33.
    Kram, M. K., Bjering, S., Hermansen, N. O., Dini, L., & Hellebostad, M. (2011). A 15-month-old girl with fever and pancytopenia. Tidsskrift for den Norske Lægeforening, 131, 2482–2486.CrossRefGoogle Scholar
  34. 34.
    Sukova, M., Stary, J., Houskova, J., & Nohynkova, E. (2002). Hemophagocytic lymphohistiocytosis as a manifestation of visceral leishmaniasis. Casopís Lékarřů Cĕských, 141, 581–584.Google Scholar
  35. 35.
    Sotoca Fernandez, J. V., Garcia Villaescusa, L., Lillo Lillo, M., Garcia Mialdea, O., Carrascosa Romero, M. C., & Tebar Gil, R. (2008). Hemophagocytic syndrome secondary to visceral leishmaniasis. Anales de Pediatría (Barcelona, Spain), 69, 46–48.CrossRefGoogle Scholar
  36. 36.
    Santamaria, M., Carrillo, J., Perez-Navero, J., Mateos, E., Ibarra, I., Fernandez, S., et al. (2008). Leishmaniasis and concurrent hemophagocytosis with or without transient perforin expression perturbation. Pediatric Blood & Cancer, 51, 310.CrossRefGoogle Scholar
  37. 37.
    Rodriguez-Cuartero, A., Salas-Galan, A., Perezgalvez, M. N., & Perez-Blanco, F. J. (1991). Haemophagocytic visceral kala azar. Infection, 19(184), 1333.Google Scholar
  38. 38.
    Lazanas, M., Perronne, C., Lomverdos, D., Galariotis, C., Arapakis, G., & Vilde, J. L. (1990). Visceral leishmaniasis disclosed by histiocytosis with erythrophagocytosis. Presse Médicale, 19, 765.Google Scholar
  39. 39.
    Rajagopala, S., Dutta, U., Chandra, K. S., Bhatia, P., Varma, N., & Kochhar, R. (2008). Visceral leishmaniasis associated hemophagocitic lymphohisticytosis. A case report and systematic review. Journal of Infection, 56(5), 381–388.PubMedCrossRefGoogle Scholar
  40. 40.
    Higel, L., Froehlich, C., Pages, M. P., Dupont, D., Collardeau-Frachon, S., Dijoud, F., et al. (2015). Macrophage activation syndrome and autoimmunity due to visceral leishmaniasis [article in French]. Archives de Pédiatrie, 22(4), 397–400. Epub 2015 Jan 22.PubMedCrossRefGoogle Scholar
  41. 41.
    Ay, Y., Yildiz, B., Unver, H., Karapinar, D. Y., & Vardar, F. (2012). Hemophagocytic lymphohistiocytosis associated with H1N1 virus infection and visceral leishmaniasis in a 4.5-month-old infant. Revista da Sociedade Brasileira de Medicina Tropical, 45(3), 407–409.PubMedCrossRefGoogle Scholar
  42. 42.
    Gaifer, Z., & Boulassel, M. R. (2016). Leishmania infantum and epstein-barr virus co-infection in a patient with hemophagocytosis. Infectious DiseaseReports, 8(4), 6545. eCollection 2016 Dec 31.Google Scholar
  43. 43.
    Koliou, M. G., Soteriades, E. S., Ephros, M., Mazeris, A., Antoniou, M., Elia, A., et al. (2008). Hemophagocytic lymphohistiocytosis associated with Epstein Barr virus and Leishmania donovani coinfection in a child from Cyprus. Journal of Pediatric Hematology/Oncology, 30, 704–707.PubMedCrossRefGoogle Scholar
  44. 44.
    Chaudary, S. R., & Arpit, M. K. (2013). Fulminant hepatic failure in kala azar, hemophagocytic lymphohistiocytosis? Pediatric Infectious Disease, 5(3), 127–129.CrossRefGoogle Scholar
  45. 45.
    Koubaa, M., Maaloul, I., Marrakchi, C., et al. (2012). Hemophagocytic syndrome associated with visceral leishmaniasis in an immunocompetent adult-case report and review of the literature. Annals of Hematology, 91(7), 1143–1145.PubMedCrossRefGoogle Scholar
  46. 46.
    Cort, P., Cardefiosa, N., & Muñoz, C. (1997). Case report Hemophagocytic syndrome associated with visceral Leishmaniasis in an Immunocompetent patient. Clinical Microbiology Newsletter, 19(2), 14–16.CrossRefGoogle Scholar
  47. 47.
    Zyurek, E., Ozcay, F., Yilmaz, B., & Ozbek, N. (2005). Hemophagocytic Lympho-histiocytosis associated with visceral leishmaniasis a case report. Pediatric Hematology and Oncology, 22, 409–414.CrossRefGoogle Scholar
  48. 48.
    Moltó, A., Mateo, L., Loveras, N., Olivé, A., & Minguez, S. (2010). Visceral Leishmaniasis and macrophage activation syndrome in a patient with rheumatoid arthritis under treatment with adalimumab. Joint, Bone, Spine, 77(3), 271–273.PubMedCrossRefPubMedCentralGoogle Scholar
  49. 49.
    Merelli, M., Quartuccio, L., Bassetti, M., Pecori, D., Gandolfo, S., Avellini, C., et al. (2015). Efficacy of intravenous cyclosporine in a case of cytophagic histiocytic panniculitis complicated by haemophagocytic syndrome after visceral leishmania infection. Clinical and Experimental Rheumatology, 33(6), 906–909.PubMedGoogle Scholar
  50. 50.
    Rios-Fernández, R., Callejas-Rubio, J. L., García-Rodríguez, S., Sancho, J., Zubiaur, M., & Ortego-Centeno, N. (2016). Tocilizumab as an adjuvant therapy for hemophagocytic lymphohistiocytosis associated with visceral leishmaniasis. American Journal of Therapeutics, 23(5), e1193–e1196.PubMedCrossRefGoogle Scholar
  51. 51.
    Martin, A., Marques, L., Soler-Palacin, P., et al. (2009). Visceral leishmaniasis associated hemophagocytic syndrome in patients with chronic granulomatous disease. The Pediatric Infectious Disease Journal, 28(8), 753–754.PubMedCrossRefGoogle Scholar
  52. 52.
    Krivokapic-Dokmanovic, L., Krstovski, N., Jankovic, S., Lazic, J., Radlovic, N., & Janic, D. (2012). Clinical characteristics and disease course in children with haemophagocytic lymphohistiocytosis treated at the university Children's Hospital in Belgrade. Srpski Arhiv za Celokupno Lekarstvo, 140, 191–197.PubMedCrossRefGoogle Scholar
  53. 53.
    Guo, X., Chen, N., Wang, T. Y., Zhou, C. Y., Li, Q., & Gao, J. (2011). Visceral leishmaniasis associated hemophagocytic lymphohistiocytosis: Report of four childhood cases. Zhonghua Er Ke Za Zhi, 49, 550–553.PubMedGoogle Scholar
  54. 54.
    Rasad, R., Muthusami, S., Pandey, N., Tilak, V., Shukla, J., & Mishra, O. P. (2009). Unusual presentations of visceral leishmaniasis. Indian Journal of Pediatrics, 76, 843–845.CrossRefGoogle Scholar
  55. 55.
    Patel, K. K., Patel, A. K., Sarda, P., Shah, B. A., & Ranjan, R. (2009). Immune reconstitution visceral leishmaniasis presented as hemophagocytic syndrome in a patient with AIDS from a nonendemic area: A case report. Journal of the International Association of Physicians in AIDS Care (Chicago, Ill.), 8, 217–220.CrossRefGoogle Scholar
  56. 56.
    Bhutani, V., Dutta, U., Das, R., & Singh, K. (2002). Hemophagocytic syndrome as the presenting manifestation of visceral leishmaniasis. The Journal of the Association of Physicians of India, 50, 838–839.PubMedGoogle Scholar
  57. 57.
    Celik, U., Alabaz, D., Alhan, E., Bayram, I., & Celik, T. (2007). Diagnostic dilemma in an adolescent boy: Hemophagocytic syndrome in association with kala azar. The American Journal of the Medical Sciences, 334, 139–141.PubMedCrossRefGoogle Scholar
  58. 58.
    Kocak, N., Eren, M., Yuce, A., & Gumruk, F. (2004). Hemophagocytic syndrome associated with visceral leishmaniasis. Indian Pediatrics, 41, 605–607.PubMedGoogle Scholar
  59. 59.
    Tapisiz, A., Belet, N., Ciftci, E., Ince, E., & Dogru, U. (2007). Hemophagocytic lymphohistiocytosis associated with visceral leishmaniasis. Journal of Tropical Pediatrics, 53, 359–361.PubMedCrossRefGoogle Scholar
  60. 60.
    Tunc, B., & Ayata, A. (2001). Hemophagocytic syndrome: A rare life-threatening complication of visceral leishmaniasis in a young boy. Pediatric Hematology and Oncology, 18, 531–536.PubMedCrossRefGoogle Scholar
  61. 61.
    Ozyurek, E., Ozcay, F., Yilmaz, B., & Ozbek, N. (2005). Hemophagocytic lymphohistiocytosis associated with visceral leishmaniasis: A case report. Pediatric Hematology and Oncology, 22, 409–414.PubMedCrossRefGoogle Scholar
  62. 62.
    Kontopoulou, T., Tsaousis, G., Vaidakis, E., Fanourgiakis, P., Michalakeas, E., Trigoni, E., et al. (2002). Hemophagocytic syndrome in association with visceral leishmaniasis. The American Journal of Medicine, 113, 439–440.PubMedCrossRefGoogle Scholar
  63. 63.
    Mathur, P., Samantaray, J. C., & Samanta, P. (2007). Fatal haemophagocytic syndrome and hepatitis associated with visceral leishmaniasis. Indian Journal of Medical Microbiology, 25, 416–418.PubMedCrossRefGoogle Scholar
  64. 64.
    Fathalla, M., Hashim, J., Alkindy, H., & Wali, Y. (2007). Cerebrospinal fluid involvement in a case of visceral leishmaniasis associated with hemophagocytic lymphohistiocytosis. Sultan Qaboos University Medical Journal, 7, 253–256.PubMedPubMedCentralGoogle Scholar
  65. 65.
    Gurgey, A., Secmeer, G., Tavil, B., Ceyhan, M., Kuskonmaz, B., Cengiz, B., et al. (2005). Secondary hemophagocytic lymphohistiocytosis in Turkish children. The Pediatric Infectious Disease Journal, 24, 1116–1117.PubMedCrossRefGoogle Scholar
  66. 66.
    Sipahi, T., Tavil, B., & Oksal, A. (2005). Visceral leishmaniasis and pseudomonas septicemia associated with hemophagocytic syndrome and myelodysplasia in a Turkish child. The Turkish Journal of Pediatrics, 47, 191–194.PubMedGoogle Scholar
  67. 67.
    Arslan, F., Batirel, A., Ramazan, M., Ozer, S., & Mert, A. (2012). Macrophage activation syndrome triggered by primary disseminated toxoplasmosis. Scandinavian Journal of Infectious Diseases, 44(12), 1001–1004. Epub 2012 Jul 17.PubMedCrossRefGoogle Scholar
  68. 68.
    Yan, K., Yang, F., Zuo, W., Hu, J., Esch, G. W., & Zuo, Y. X. (2013). The American society of tropical medicine and hygiene short report: Hemophagocytic syndrome as uncommon presentation of disseminated toxoplasmosis in an immunocompetent adult from Chinese. The American Journal of Tropical Medicine and Hygiene, 88(6), 1209–1211.CrossRefGoogle Scholar
  69. 69.
    Undseth, Ø., Gerlyng, P., Goplen, A. K., Holter, E. S., von der Lippe, E., & Dunlop, O. (2014). Primary toxoplasmosis with critical illness and multi-organ failure in an immunocompetent young man. Scandinavian Journal of Infectious Diseases, 46(1), 58–62.PubMedCrossRefGoogle Scholar
  70. 70.
    Duband, S., Cornillon, J., Tavernier, E., Dumollard, J. M., & Guyotat, D. (2008). Pe’oc’h M,.Toxoplasmosis with hemophagocytic syndrome after bone marrow transplantation: Diagnosis at autopsy. Transplant Infectious Disease, 10, 372–374.PubMedCrossRefPubMedCentralGoogle Scholar
  71. 71.
    Briand, P. Y., Gangneux, J. P., Favaretto, G., Ly-Sunnaram, B., Godard, M., Robert-Gangneux, F., et al. (2008). Hemophagocytic syndrome and toxoplasmic primo-infection. Annales de Biologie Clinique, 66(2), 199–205.PubMedGoogle Scholar
  72. 72.
    Hebraud, B., Kamar, N., Borde, J. S., Bessieres, M. H., & Galinier, M. (2008). Rostaing l. unusual presentation of primary toxoplasmosis infection in a kidney transplant patient complicated by an acute left ventricular failure. NDT Plus, 1, 429–432.PubMedPubMedCentralGoogle Scholar
  73. 73.
    Segall, L., Moal, M. C., Doucet, L., Kergoat, N., & Bourbigot, B. (2006). Toxoplasmosis-associated hemophagocytic syndrome in renal transplantation. Transplant International, 19, 78–80.PubMedCrossRefGoogle Scholar
  74. 74.
    Guillaume, M. P., Driessens, N., Libert, M., De Bels, D., Corazza, F., & Karmali, R. (2006). Hemophagocytic syndrome associated with extracerebral toxoplasmosis in an HIV-infected patient. European Journal of Internal Medicine, 17, 503–504.PubMedCrossRefGoogle Scholar
  75. 75.
    Blanche, P., Robert, F., Dupouy-Camet, J., & Sicard, D. (1994). Toxoplasmosis-associated hemophagocytic syndrome in a patient with AIDS: Diagnosis by the polymerase chain reaction. Clinical Infectious Diseases, 19, 989–990.PubMedCrossRefGoogle Scholar
  76. 76.
    D’Errico, M. M., Cuoco, F., Biancardi, C., Torcoletti, M., Filocamo, G., & Corona, F. (2014). Macrophage activation syndrome: The role of infectious triggers. Pediatric Rheumatology Online Journal, 12(Sup. 1), Y5.PubMedCentralCrossRefPubMedGoogle Scholar
  77. 77.
    Auerbach, M., Haubenstock, A., & Soloman, G. (1986). Systemic babesiosis. Another cause of the hemophagocytic syndrome. The American Journal of Medicine, 80, 301–303.PubMedCrossRefGoogle Scholar
  78. 78.
    Slovut, D. P., Benedetti, E., & Matas, A. J. (1996). Babesiosis and hemophagocytic syndrome in an asplenic renal transplant recipient. Transplantation, 62, 537–539.PubMedCrossRefGoogle Scholar
  79. 79.
    Gupta, P., Hurley, R. W., Helseth, P. H., Goodman, J. L., & Hammerschmidt, D. E. (1995). Pancytopenia due to hemophagocytic syndrome as a presenting manifestation of babesiosis. American Journal of Hematology, 50, 60–62.PubMedCrossRefGoogle Scholar
  80. 80.
    Bayhan, G. İ., Çenesiz, F., Tanır, G., Taylan Özkan, A., & Çınar, G. (2015). First case of Ascaris lumbricoides infestation complicated with Hemophagocytic Lymphohistiocytosis. Turkish Journal of Parasitology (Türkiye Parazitol Derg), 39, 2.Google Scholar
  81. 81.
    Trapani, S., Canessa, C., Fedi, A., Giusti, G., Barni, S., Montagnani, C., et al. (2013). Macrophage activation syndrome in a child affected by malaria: The choice of steroid. International Journal of Immunopathology and Pharmacology, 26(2), 535–539.PubMedCrossRefGoogle Scholar
  82. 82.
    Sudhakara, R., Sivajothi, S., Varaprasad, R., & Solmon, R. (2016). Clinical and laboratory findings of Babesia infection in dogs. Journal of Parasitic Diseases, 40(2), 268–272.CrossRefGoogle Scholar
  83. 83.
    Vannier, E., & Krause, P. J. (2012). Human babesiosis. The New England Journal of Medicine, 366, 2397–2407.PubMedCrossRefGoogle Scholar
  84. 84.
    Zavala, G. A., García, O. P., Camacho, M., Ronquillo, D., Campos-Ponce, M., Doak, C., et al. (2018). Intestinal parasites: Associations with intestinal and systemic inflammation. Parasite Immunology, 40(4), e12518.PubMedPubMedCentralCrossRefGoogle Scholar
  85. 85.
    Pigott, D. M., Golding, N., Messina, J. P., Battle, K. E., Duda, K. A., Balard, Y., et al. (2014). Global database of leishmaniasis occurrence locations, 1960–20. Scientific Data, 1, 140036.PubMedPubMedCentralCrossRefGoogle Scholar
  86. 86.
    Boalaert, M., Verdonck, K., Menten, J., Sunyoto, T., Griensven, J. V., Chappuis, F., et al. (2014). Rapid test for the diagnosis of visceral leishmaniasis in patients with suspected disease. Cochrane Database of Systematic Reviews, 6, 1–119.Google Scholar
  87. 87.
    Bouguila, J., Chabchoub, I., Moncef, Y., Mlika, A., Saghrouni, F., Boughamoura, L., et al. (2010). Treatment of severe hemophagocytic syndrome associated with visceral leishmaniasis. Archives de Pédiatrie, 17, 1566–1570.PubMedCrossRefGoogle Scholar
  88. 88.
    Chaichan, P., Mercier, A., Galal, L., Mahittikorn, A., Ariey, F., Morand, S., et al. (2017). Geographical distribution of toxoplasma gondii genotypes in Asia: A link with neighboring continents. Infection, Genetics and Evolution, 53, 227–238. Epub 2017 Jun 3.PubMedCrossRefPubMedCentralGoogle Scholar
  89. 89.
    Numata, K., Tsutsumi, H., Wakai, S., Tachi, N., & Chiba, S. (1998). A child case of haemophagocytic syndrome associated with cryptococcal meningoencephalitis. The Journal of Infection, 36(1), 118–119.PubMedCrossRefGoogle Scholar
  90. 90.
    Powel, M. S., Alizadeh, A. A., Budvytiene, I., Schaenman, J. M., & Banaei, N. (2012). First isolation of Cryptococcus uzbekistanensis from an Immunocompromised patient with lymphoma. Journal of Clinical Microbiology, 50(3), 1125–1127.PubMedPubMedCentralCrossRefGoogle Scholar
  91. 91.
    Chandra, H., Chandra, S., & Sharma, A. (2012). Histoplasmosis on bone marrow aspirate: Cytological examination associated with haemophagocytosis and pancytopenia in an AIDS patient. The Korean journal of hematology, 47, 77–79.PubMedPubMedCentralCrossRefGoogle Scholar
  92. 92.
    Kumar, N., Jain, S., & Singh, Z. N. (2000). Disseminated histoplasmosis with reactive haemophagocytosis: Aspiration cytology findings in two cases. Diagnostic Cytopathology, 23, 422–424.PubMedCrossRefPubMedCentralGoogle Scholar
  93. 93.
    Sonawane, P. B., Chandak, S. V., & Rathi, P. M. (2016). Disseminated histoplasmosis with haemophagocytic lymphohistiocytosis in an immunocompetent host. Journal of Clinical and Diagnostic Research, 10(3), OD03–OD05.PubMedPubMedCentralGoogle Scholar
  94. 94.
    Saluja, S., Sunita, Bhasin, S., Gupta, D. K., Gupta, B., Kataria, S. P., et al. (2005). Disseminated histoplasmosis with reactive haemophagocytosis presenting as PUO in an immunocompetent host. The Journal of the Association of Physicians of India, 53, 906–908.PubMedPubMedCentralGoogle Scholar
  95. 95.
    De, D., & Nath, U. K. (2015). Disseminated Histoplasmosis in Immunocompetent individuals- not a so rare entity, in India. Mediterranean Journal of Hematology and Infectious Diseases, 7(1), 45.Google Scholar
  96. 96.
    Phillips, J., Staszewski, H., & Garrison, M. (2008). Successful treatment of secondary hemophagocytic lymphohistiocytosis in a patient with disseminated histoplasmosis. Hematology, 13(5), 282–285.PubMedCrossRefPubMedCentralGoogle Scholar
  97. 97.
    Wang, Z., Duarte, A. G., & Schnadig, V. J. (2007). Fatal reactive hemophagocytosis related to disseminated histoplasmosis with endocarditis: An unusual case diagnosed at autopsy. Southern Medical Journal, 100(2), 208–211.PubMedCrossRefPubMedCentralGoogle Scholar
  98. 98.
    Masri, K., Mahon, N., Rosario, A., Mirza, L., Keys, T. F., Ratliff, N. B., et al. (2003). Reactive hemophagocytic syndrome associated with disseminated histoplasmosis in a heart transplant recipient. The Journal of Heart and Lung Transplantation, 22, 487–491.PubMedCrossRefPubMedCentralGoogle Scholar
  99. 99.
    Van Koeveringe, M. P., & Brouwer, R. E. (2010). Histoplasma capsulatum reactivation with haemophagocytic syndrome in a patient with chronic lymphocytic leukaemia. The Netherlands Journal of Medicine, 68, 418–421.PubMedPubMedCentralGoogle Scholar
  100. 100.
    Rao, R. D., Morice, W. G., & Phyliky, R. L. (2002). Hemophagocytosis in a patient with chronic lymphocytic leukemia and histoplasmosis. Mayo Clinic Proceedings, 77, 287–290.PubMedCrossRefPubMedCentralGoogle Scholar
  101. 101.
    Majluf-Cruz, A., Hurtado Monroy, R., Souto-Meirino, C., Del Rio Chiriboga, C., & Simon, J. (1993). Hemophagocytic syndrome associated with histoplasmosis in the acquired immunodeficiency syndrome: Description of 3 cases and review of the literature. Sangre (Barc), 38, 51–55.Google Scholar
  102. 102.
    Supparatpinyo, K., Khamwan, C., Baosoung, V., Nelson, K. E., & Sirisanthana, T. (1994). Disseminated P. marneffei infection in Southeast Asia. Lancet, 344, 110–113.PubMedCrossRefPubMedCentralGoogle Scholar
  103. 103.
    Abughanimeh, O., Qasrawi, A., & Abu Ghanimeh, M. (2018). Hemophagocytic Lymphohistiocytosis Complicating Systemic Sarcoidosis. Cureus, 10(6), e2838.PubMedPubMedCentralGoogle Scholar
  104. 104.
    Chokephaibulkit, K., Veerakul, G., Vanprapar, N., Chaiprasert, A., Tanphaichitr, V., & Chearskul, S. (2001). Penicilliosis-associated hemophagocytic syndrome in a human immunodeficiency virus-infected child: The first case report in children. Journal of the Medical Association of Thailand, 84(3), 426–429.PubMedPubMedCentralGoogle Scholar
  105. 105.
    Pei, S. N., Lee, C. H., & Liu, J. W. (2008). Hemophagocytic syndrome in a patient with acquired immunodeficiency syndrome and acute disseminated penicilliosis. The American Journal of Tropical Medicine and Hygiene, 78, 11–13.PubMedCrossRefPubMedCentralGoogle Scholar
  106. 106.
    Chim, C. S., Fong, C. Y., Ma, S. K., Wong, S. S., & Yuen, K. Y. (1998). Reactive hemophagocytic syndrome associated with Penicillium marneffei infection. The American Journal of Medicine, 104(2), 196–197.PubMedCrossRefPubMedCentralGoogle Scholar
  107. 107.
    Bhatia, S., Bauer, F., & Bilgrami, S. A. (2003). Candidiasis-associated hemophagocytic lymphohistiocytosis in a patient infected with human immunodeficiency virus. Clinical Infectious Diseases, 37(11), e161–e166.PubMedCrossRefPubMedCentralGoogle Scholar
  108. 108.
    Valentine, G., Thomas, T. A., Nguyen, T., & Lai, Y. C. (2014). Chronic granulomatous disease presenting as hemophagocytic lymphohistiocytosis: A case report. Pediatrics, 134(6), e1727–e1730.CrossRefGoogle Scholar
  109. 109.
    Mustafa Ali, M., Ruano Mendez, A. L., & Carraway, H. E. (2017). Hemophagocytic Lymphohistiocytosis in a patient with Hodgkin lymphoma and concurrent EBV, CMV, and Candida infections. Journal of Investigative Medicine High Impact Case Reports, 5(1), 2324709616684514.PubMedPubMedCentralCrossRefGoogle Scholar
  110. 110.
    González-Posada, J. M., Hernández, D., Martin, A., Raya, J. M., Pitti, S., Bonilla, A., et al. (2008). Hemophagocytic lymphohistiocytosis in a pancreas-kidney transplant recipient: Response to dexamethasone and cyclosporine. Clinical Nephrology, 70(1), 82–86.PubMedCrossRefPubMedCentralGoogle Scholar
  111. 111.
    Machaczka, M., & Vaktnas, J. (2007). Haemophagocytic syndrome associated with Hodgkin lymphoma and pneumocystis jirovecii pneumonitis. British Journal of Haematology, 138(6), 672.PubMedCrossRefGoogle Scholar
  112. 112.
    Watanabe, E., Sugawara, H., Yamashita, T., Ishii, A., Oda, A., & Tera, C. H. (2016). Successful tocilizumab therapy for macrophage activation syndrome associated with adult-onset still’s disease: A case-based review. Case Reports in Medicine, 2016, 5656320.Google Scholar
  113. 113.
    Karras, A., Thervet, E., & Legendre, C. (2004). Hemophagocytic syndrome in renal transplant recipients: Report of 17 cases and review of literature. Transplantation, 77(2), 238–243.CrossRefGoogle Scholar
  114. 114.
    Baddley, J. W., Winthrop, K. L., Patkar, N. M., Delzell, E., Beukelman, T., & Xie, F. (2011). Geographic distribution of endemic fungal infections among older persons, United States. Emerging Infectious Diseases, 17(9), 1664–1669.PubMedPubMedCentralCrossRefGoogle Scholar
  115. 115.
    Colombo, A. L., Tobon, A., Restrepo, A., Queiroz-Telles, F., & Nucci, M. (2011). Epidemiology of endemic systemic fungal infections in Latin America. Medical Mycology, 49(8), 785–798.PubMedGoogle Scholar
  116. 116.
    Vaid, N., & Patel, P. (2011). A case of haemophagocytic syndrome in HIV associated disseminated histoplasmosis. Acute Medicine, 10, 142–144.PubMedGoogle Scholar
  117. 117.
    Chemlal, K., Andrieu-Bautru, V., & Couvelard, A. (1997). Hemophagocytic syndrome during Histoplasma capsulatum infection. Haematologica, 82(6), 726.PubMedGoogle Scholar
  118. 118.
    Koduri, P. R., Chundi, V., DeMarais, P., Mizock, B. A., Patel, A. R., & Weinstein, R. A. (1995). Reactive hemophagocytic syndrome: A new presentation of disseminated histoplasmosis in patients with AIDS. Clinical Infectious Diseases, 21, 1463–1465.PubMedCrossRefGoogle Scholar
  119. 119.
    Mukherjee, T., & Basu, A. (2015). Disseminated histoplasmosis presenting as a case of erythema nodosum and haemophagocytic Lymphohistiocytosis. Medical Journal, Armed Forces India, 71(Suppl 2), S598–S600.PubMedPubMedCentralCrossRefGoogle Scholar
  120. 120.
    Sanchez, A., Celaya, A. K., & Victorio, A. (2007). Histoplasmosis-associated hemophagocytic syndrome: A case report. The AIDS Reader, 17, 496–499.PubMedGoogle Scholar
  121. 121.
    Nieto, J. F., Gómez, S. M., Moncada, D. C., Serna, L. M., & Hidrón, A. I. (2016). Successful treatment of hemophagocytic lymphohistiocytosis and disseminated intravascular coagulation secondary to histoplasmosis in a patient with HIV/AIDS. Biomédica, 36(0), 9–14.Google Scholar
  122. 122.
    Townsend, J. L., Shanbhag, S., Hancock, J., Bowman, K., & Nijhawan, A. E. (2015). Histoplasmosis-induced hemophagocytic syndrome: A case series and review of the literature. Open Forum Infectious Diseases, 2(2), ofv055.PubMedPubMedCentralCrossRefGoogle Scholar
  123. 123.
    Agarwal, S., Moodley, J., Ajani Goel, G., Theil, K. S., Mahmood, S. S., & Lang, R. S. (2009). A rare trigger for macrophage activation syndrome. Rheumatology International, 31, 405–407.PubMedCrossRefGoogle Scholar
  124. 124.
    Lo, M. M., Mo, J. Q., Dixon, B. P., & Czech, K. A. (2010). Disseminated histoplasmosis associated with hemophagocytic lymphohistiocytosis in kidney transplant recipients. American Journal of Transplantation, 10, 687–691.PubMedCrossRefGoogle Scholar
  125. 125.
    Keller, F. G., & Kurtzberg, J. (1994). Disseminated histoplasmosis: A cause of infection-associated hemophagocytic syndrome. The American Journal of Pediatric Hematology/Oncology, 16, 368–371.PubMedGoogle Scholar
  126. 126.
    Guiot, H. M., Bertran-Pasarell, J., Tormos, L. M., Gonzalez-Keelan, C., Procop, G. W., Fradera, J., et al. (2007). Ileal perforation and reactive hemophagocytic syndrome in a patient with disseminated histoplasmosis: The role of the real-time polymerase chain reaction in the diagnosis and successful treatment with amphotericin B lipid complex. Diagnostic Microbiology and Infectious Disease, 57, 429–433.PubMedCrossRefPubMedCentralGoogle Scholar
  127. 127.
    Gil-Brusola, A., Peman, J., Santos, M., Salavert, M., Lacruz, J., & Gobernado, M. (2007). Disseminated histoplasmosis with hemophagocytic syndrome in a patient with AIDS: Description of one case and review of the Spanish literature. Revista Iberoamericana de Micología, 24, 312–316.PubMedCrossRefGoogle Scholar
  128. 128.
    Mehta, B. M., Hashkes, P. J., Avery, R., & Deal, C. L. (2010). A 21-year-old man with Still's disease with fever, rash, and pancytopenia. Arthritis Care & Research (Hoboken), 62, 575–579.CrossRefGoogle Scholar
  129. 129.
    Ponce, C. A., Gallo, M., Bustamante, R., & Vargas, S. L. (2010). Pneumocystis colonization is highly prevalent in the autopsied lungs of the general population. Clinical Infectious Diseases, 50(3), 347–353.PubMedCrossRefPubMedCentralGoogle Scholar
  130. 130.
    Deng, Z., Ribas, J. L., Gibson, D. W., & Connor, D. H. (1988). Infections caused by Penicillium marneffei in China and Southeast Asia: Review of eighteen published cases and report of four more Chinese cases. Reviews of Infectious Diseases, 10, 640–652.PubMedCrossRefGoogle Scholar
  131. 131.
    World Health Organization. (2007). WHO case definitions of HIV for surveillance and revised clinical staging and immunological classification of HIV-related disease in adults and children. WHO press.Google Scholar
  132. 132.
    Le, T., Wolbers, M., Chi, N. H., et al. (2011). Epidemiology, seasonality, and predictors of outcome of AIDS-associated Penicillium marneffei infection in Ho Chi Minh City, Viet Nam. Clinical Infectious Diseases, 52, 945–952.PubMedPubMedCentralCrossRefGoogle Scholar
  133. 133.
    Antinori, S., Gianelli, E., Bonaccorso, C., et al. (2006). Disseminated Penicillium marneffei infection in an HIV-positive Italian patient and a review of cases reported outside endemic regions. Journal of Travel Medicine, 13, 181–188.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  • Gary Sterba
    • 1
  • Yonit Sterba
    • 2
  1. 1.South Miami Hospital, Baptist systemMiamiUSA
  2. 2.Nicklaus Children’s HospitalMiamiUSA

Personalised recommendations